Please assess the completion status of the following clinical trial:

Trial Title: Vitamin E Treatment for Long-Chain 3-Hydroxyacyl Coenzyme A (CoA) Dehydrogenase (LCHAD) Associated Neuropathy

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Confirmed diagnosis of TFP, or LCHAD deficiency and progressive peripheral neuropathy~* Subjects must be \> 7 years of age, and be willing to take vitamin E supplements.~Exclusion Criteria:~* None

- Gender: ALL
- Minimum Age: 7 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- LCHAD/TFP with peripheral neuropathy (Type: EXPERIMENTAL): Subjects diagnosed with LCHAD or TFP and with documented peripheral neuropathy

Based on this trial design, predict the completion outcome and termination type (if applicable).